New insights regarding HCV-NS5A structure/function and indication of genotypic differences

Virology Journal

Paula Rahal⁴  Isabel Maria VG de Carvalho-Mello³  Cintia Bittar⁴  Ana Carolina G Jardim⁴  Helen A Arcuri¹  Lilian HT Yamasaki² 

[1] Department of Clinical Medicine, Sao Paulo University--USP, Medicine College, Sao Paulo, SP, Brazil;Rua Cristovao Colombo, 2265 Laboratorio de Estudos Genomicos, Jardim Nazareth, CEP: 15054-000, Sao Jose do Rio Preto, SP, Brazil;Viral Immunology Laboratory, Butantan Institute, Sao Paulo, SP, Brazil;Department of Biology, Sao Paulo State University--UNESP, Sao Jose do Rio Preto, SP, Brazil

关键词: IFN response;    Quasispecies;    Genotype;    Bioinformatics;    Non-structural 5A protein;    Hepatitis C virus;   

Others  :  1155238
DOI  :  10.1186/1743-422X-9-14

 received in 2011-07-05, accepted in 2012-01-12,  发布年份 2012

【 摘 要 】

Background

HCV is prevalent throughout the world. It is a major cause of chronic liver disease. There is no effective vaccine and the most common therapy, based on Peginterferon, has a success rate of ~50%. The mechanisms underlying viral resistance have not been elucidated but it has been suggested that both host and virus contribute to therapy outcome. Non-structural 5A (NS5A) protein, a critical virus component, is involved in cellular and viral processes.

Methods

The present study analyzed structural and functional features of 345 sequences of HCV-NS5A genotypes 1 or 3, using in silico tools.

Results

There was residue type composition and secondary structure differences between the genotypes. In addition, second structural variance were statistical different for each response group in genotype 3. A motif search indicated conserved glycosylation, phosphorylation and myristoylation sites that could be important in structural stabilization and function. Furthermore, a highly conserved integrin ligation site was identified, and could be linked to nuclear forms of NS5A. ProtFun indicated NS5A to have diverse enzymatic and nonenzymatic activities, participating in a great range of cell functions, with statistical difference between genotypes.

Conclusion

This study presents new insights into the HCV-NS5A. It is the first study that using bioinformatics tools, suggests differences between genotypes and response to therapy that can be related to NS5A protein features. Therefore, it emphasizes the importance of using bioinformatics tools in viral studies. Data acquired herein will aid in clarifying the structure/function of this protein and in the development of antiviral agents.

【 授权许可】

   
2012 Yamasaki et al; licensee BioMed Central Ltd

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Gale M Jr, Foy EM: Evasion of intracellular host defence by hepatitis C virus. Nature 2005, 436:939-945.
• [2]Appel N, Zayas M, Miller S, Krijnse-Locker J, Schaller T, Friebe P, Kallis S, Engel U, Bartenschlager R: Essential role of domain III of nonstructural protein 5A for hepatitis C virus infectious particle assembly. PLoS Pathog 2008, 4:e1000035.
• [3]Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo QL, Kuo G: Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989, 321:1494-1500.
• [4]Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, et al.: Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990, 87:6547-6549.
• [5]Simmonds P: Genetic diversity and evolution of hepatitis C virus-15 years on. J Gen Virol 2004, 85:3173-3188.
• [6]Kuiken C, Simmonds P: Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol 2009, 510:33-53.
• [7]Moradpour D, Cerny A, Heim MH, Blum HE: Hepatitis C: an update. Swiss Med Wkly 2001, 131:291-298.
• [8]Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, Harvey PH: The epidemic behavior of the hepatitis C virus. Science 2001, 292:2323-2325.
• [9]Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS: Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998, 282:103-107.
• [10]Moradpour D, Blum HE: A primer on the molecular virology of hepatitis C. Liver Int 2004, 24:519-525.
• [11]Lyra AC, Fan X, Di Bisceglie AM: Molecular biology and clinical implication of hepatitis C virus. Braz J Med Biol Res 2004, 37:691-695.
• [12]Kamar N, Bendall RP, Peron JM, Cintas P, Prudhomme L, Mansuy JM, Rostaing L, Keane F, Ijaz S, Izopet J, Dalton HR: Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011, 17:173-179.
• [13]Reed KE, Xu J, Rice CM: Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase. J Virol 1997, 71:7187-7197.
• [14]Macdonald A, Harris M: Hepatitis C virus NS5A: tales of a promiscuous protein. J Gen Virol 2004, 85:2485-2502.
• [15]Liang Y, Ye H, Kang CB, Yoon HS: Domain 2 of nonstructural protein 5A (NS5A) of hepatitis C virus is natively unfolded. Biochemistry 2007, 46:11550-11558.
• [16]Love RA, Brodsky O, Hickey MJ, Wells PA, Cronin CN: Crystal structure of a novel dimeric form of NS5A domain I protein from hepatitis C virus. J Virol 2009, 83:4395-4403.
• [17]Tellinghuisen TL, Marcotrigiano J, Gorbalenya AE, Rice CM: The NS5A protein of hepatitis C virus is a zinc metalloprotein. J Biol Chem 2004, 279:48576-48587.
• [18]Moradpour D, Brass V, Penin F: Function follows form: the structure of the N-terminal domain of HCV NS5A. Hepatology 2005, 42:732-735.
• [19]Brass V, Bieck E, Montserret R, Wolk B, Hellings JA, Blum HE, Penin F, Moradpour D: An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A. J Biol Chem 2002, 277:8130-8139.
• [20]Liu S, Ansari IH, Das SC, Pattnaik AK: Insertion and deletion analyses identify regions of non-structural protein 5A of Hepatitis C virus that are dispensable for viral genome replication. J Gen Virol 2006, 87:323-327.
• [21]Verdegem D, Badillo A, Wieruszeski JM, Landrieu I, Leroy A, Bartenschlager R, Penin F, Lippens G, Hanoulle X: Domain 3 of NS5A protein from the hepatitis C virus has intrinsic {alpha}-helical propensity and is a substrate of Cyclophilin A. J Biol Chem 2011.
• [22]Wohnsland A, Hofmann WP, Sarrazin C: Viral determinants of resistance to treatment in patients with hepatitis C. Clin Microbiol Rev 2007, 20:23-38.
• [23]Neumann AU, Lam NP, Dahari H, Davidian M, Wiley TE, Mika BP, Perelson AS, Layden TJ: Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. J Infect Dis 2000, 182:28-35.
• [24]Jardim AC, Yamasaki LH, de Queiroz AT, Bittar C, Pinho JR, Carareto CM, Rahal P, Mello IM: Quasispecies of hepatitis C virus genotype 1 and treatment outcome with peginterferon and ribavirin. Infect Genet Evol 2009, 9:89-698.
• [25]Bittar C, Jardim AC, Yamasaki LH, de Queiroz AT, Carareto CM, Pinho JR, de Carvalho-Mello IM, Rahal P: Genetic diversity of NS5A protein from hepatitis C virus genotype 3a and its relationship to therapy response. BMC Infect Dis 2010, 10:36. BioMed Central Full Text
• [26]Tsai YH, Kuang WF, Lu TY, Kao JH, Lai MY, Liu CJ, Chen PJ, Hwang LH: The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism. J Hepatol 2008, 49:899-907.
• [27]Kang SM, Won SJ, Lee GH, Lim YS, Hwang SB: Modulation of interferon signaling by hepatitis C virus non-structural 5A protein: implication of genotypic difference in interferon treatment. FEBS Lett 2010, 584:4069-4076.
• [28]Scheel TK, Gottwein JM, Mikkelsen LS, Jensen TB, Bukh J: Recombinant HCV variants with NS5A from genotypes 1-7 have different sensitivities to an NS5A inhibitor but not interferon-alpha. Gastroenterology 2011, 140:1032-1042.
• [29]Schreiber G, Keating AE: Protein binding specificity versus promiscuity. Curr Opin Struct Biol 2011, 21:50-61.
• [30]Taylor ME, Drickamer K: Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. J Biol Chem 1993, 268:399-404.
• [31]Petrescu AJ, Milac AL, Petrescu SM, Dwek RA, Wormald MR: Statistical analysis of the protein environment of N-glycosylation sites: implications for occupancy, structure, and folding. Glycobiology 2004, 14:103-114.
• [32]Graff J, Zhou YH, Torian U, Nguyen H, St Claire M, Yu C, Purcell RH, Emerson SU: Mutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles. J Virol 2008, 82:1185-1194.
• [33]Helenius A: How N-linked oligosaccharides affect glycoprotein folding in the endoplasmic reticulum. Mol Biol Cell 1994, 5:253-265.
• [34]Hart GW, Haltiwanger RS, Holt GD, Kelly WG: Glycosylation in the nucleus and cytoplasm. Annu Rev Biochem 1989, 58:841-874.
• [35]Pedemonte CH, Sachs G, Kaplan JH: An intrinsic membrane glycoprotein with cytosolically oriented n-linked sugars. Proc Natl Acad Sci USA 1990, 87:9789-9793.
• [36]Kreppel LK, Blomberg MA, Hart GW: Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem 1997, 272:9308-9315.
• [37]Hart GW: Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 1997, 66:315-335.
• [38]Masaki T, Suzuki R, Murakami K, Aizaki H, Ishii K, Murayama A, Date T, Matsuura Y, Miyamura T, Wakita T, Suzuki T: Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol 2008, 82:7964-7976.
• [39]Huang Y, Staschke K, De Francesco R, Tan SL: Phosphorylation of hepatitis C virus NS5A nonstructural protein: a new paradigm for phosphorylation-dependent viral RNA replication? Virology 2007, 364:1-9.
• [40]Tellinghuisen TL, Foss KL, Treadaway JC, Rice CM: Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein. J Virol 2008, 82:1073-1083.
• [41]Neddermann P: NS5A phosphorylation and hyperphosphorylation. Methods Mol Biol 2009, 510:95-110.
• [42]Gordon JI, Duronio RJ, Rudnick DA, Adams SP, Gokel GW: Protein N-myristoylation. J Biol Chem 1991, 266:8647-8650.
• [43]Farazi TA, Waksman G, Gordon JI: The biology and enzymology of protein N-myristoylation. J Biol Chem 2001, 276:39501-39504.
• [44]Ruoslahti E, Pierschbacher MD: Arg-Gly-Asp: a versatile cell recognition signal. Cell 1986, 44:517-518.
• [45]Rovere C, Luis J, Lissitzky JC, Basak A, Marvaldi J, Chretien M, Seidah NG: The RGD motif and the C-terminal segment of proprotein convertase 1 are critical for its cellular trafficking but not for its intracellular binding to integrin alpha5beta1. J Biol Chem 1999, 274:12461-12467.
• [46]Oba M, Aoyagi K, Miyata K, Matsumoto Y, Itaka K, Nishiyama N, Yamasaki Y, Koyama H, Kataoka K: Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking. Mol Pharm 2008, 5:1080-1092.
• [47]Ide Y, Zhang L, Chen M, Inchauspe G, Bahl C, Sasaguri Y, Padmanabhan R: Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 1996, 182:203-211.
• [48]Kim JE, Song WK, Chung KM, Back SH, Jang SK: Subcellular localization of hepatitis C viral proteins in mammalian cells. Arch Virol 1999, 144:329-343.
• [49]Song J, Nagano-Fujii M, Wang F, Florese R, Fujita T, Ishido S, Hotta H: Nuclear localization and intramolecular cleavage of N-terminally deleted NS5A protein of hepatitis C virus. Virus Res 2000, 69:109-117.
• [50]Hidajat R, Nagano-Fujii M, Deng L, Hotta H: Cleavage of the hepatitis C virus NS5A protein by caspase-3 in the interferon sensitivity-determining region in a sequence-dependent manner. Kobe J Med Sci 2004, 50:153-166.
• [51]Kalamvoki M, Georgopoulou U, Mavromara P: The NS5A protein of the hepatitis C virus genotype 1a is cleaved by caspases to produce C-terminal-truncated forms of the protein that reside mainly in the cytosol. J Biol Chem 2006, 281:13449-13462.
• [52]Tanimoto A, Ide Y, Arima N, Sasaguri Y, Padmanabhan R: The amino terminal deletion mutants of hepatitis C virus nonstructural protein NS5A function as transcriptional activators in yeast. Biochem Biophys Res Commun 1997, 236:360-364.
• [53]Fukuma T, Enomoto N, Marumo F, Sato C: Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein. Hepatology 1998, 28:1147-1153.
• [54]Sauter D, Himmelsbach K, Kriegs M, Carvajal Yepes M, Hildt E: Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication. J Hepatol 2009, 50:861-871.
• [55]Marucci EA, Zafalon GF, Jardim AC, Yamasaki LH, Bittar C, Rahal P, Machado JM: Routine libraries for pattern recognition in quasispecies. Genet Mol Res 2008, 7:970-981.
• [56]Rost B, Sander C: Improved prediction of protein secondary structure by use of sequence profiles and neural networks. Proc Natl Acad Sci USA 1993, 90:7558-7562.
• [57]Rost B, Yachdav G, Liu J: The predictprotein server. Nucleic Acids Res 2004, 32:W321-W326.
• [58]Jones DT: Improving the accuracy of transmembrane protein topology prediction using evolutionary information. Bioinformatics 2007, 23:538-544.
• [59]Bairoch A, Bucher P, Hofmann K: The PROSITE database, its status in 1997. Nucleic Acids Res 1997, 25:217-221.
• [60]Jensen LJ, Gupta R, Blom N, Devos D, Tamames J, Kesmir C, Nielsen H, Staerfeldt HH, Rapacki K, Workman C, et al.: Prediction of human protein function from post-translational modifications and localization features. J Mol Biol 2002, 319:1257-1265.
• [61]Jensen LJ, Ussery DW, Brunak S: Functionality of system components: conservation of protein function in protein feature space. Genome Res 2003, 13:2444-2449.
• [62]Lenth RV: Java Applets for Power and Sample Size [Computer software]. [http://www.stat.uiowa.edu/~rlenth/Power/] webciteJava Applets for Power and Sample Size2006-9.